RUNX3 and esophageal cancer: Although these two esophageal cancers are different in pathogenesis, epidemiology, tumor biology, prognosis and therapeutic strategies among the pooled patients in this meta analysis, RUNX3 methylation/low expression was associated with the pathogenesis of both types of esophageal cancer, indicating that RUNX3 might be responsible for different patterns of tumorigenesis.